Company Analysis Torrent Pharmaceuticals Limited
1. Summary
Advantages
- The stock's return over the last year (50.94%) is higher than the sector average (39.02%).
- The company's current efficiency (ROE=25.38%) is higher than the sector average (ROE=17.13%)
Disadvantages
- Price (3350.65 βΉ) is higher than fair price (622.07 βΉ)
- Dividends (1.09%) are below the sector average (12.08%).
- Current debt level 26.14% has increased over 5 years from 0%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Torrent Pharmaceuticals Limited | Index | ||
|---|---|---|---|
| 7 days | -0.8% | -1.8% | -2.9% |
| 90 days | -2.1% | 0.6% | -4.6% |
| 1 year | 50.9% | 39% | 8.7% |
TORNTPHARM vs Sector: Torrent Pharmaceuticals Limited has outperformed the "" sector by 11.92% over the past year.
TORNTPHARM vs Market: Torrent Pharmaceuticals Limited has outperformed the market by 42.21% over the past year.
Stable price: TORNTPHARM is not significantly more volatile than the rest of the market on "Bombay Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: TORNTPHARM with weekly volatility of 0.9797% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (3350.65 βΉ) is higher than the fair price (622.07 βΉ).
Price is higher than fair: The current price (3350.65 βΉ) is 81.4% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (52.33) is higher than that of the sector as a whole (45.31).
P/E vs Market: The company's P/E (52.33) is higher than that of the market as a whole (43.66).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (12.64) is higher than that of the sector as a whole (6.25).
P/BV vs Market: The company's P/BV (12.64) is higher than that of the market as a whole (6.15).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (8.21) is higher than that of the sector as a whole (5.02).
P/S vs Market: The company's P/S indicator (8.21) is lower than that of the market as a whole (8.67).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (19.65) is higher than that of the sector as a whole (13.54).
EV/Ebitda vs Market: The company's EV/Ebitda (19.65) is higher than that of the market as a whole (15.13).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 12.33% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (12.33%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-37.97%).
5.4. ROE
ROE vs Sector: The company's ROE (25.38%) is higher than that of the sector as a whole (17.13%).
ROE vs Market: The company's ROE (25.38%) is higher than that of the market as a whole (-0.3088%).
5.5. ROA
ROA vs Sector: The company's ROA (11.02%) is higher than that of the sector as a whole (10.35%).
ROA vs Market: The company's ROA (11.02%) is higher than that of the market as a whole (7.53%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (19.66%) is higher than that of the sector as a whole (10.89%).
ROIC vs Market: The company's ROIC (19.66%) is higher than that of the market as a whole (16.2%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 1.09% is below the average for the sector '12.08%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 1.09% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 1.09% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (61.28%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
